Catch Up On Our Highlights From Phacilitate's ATW 2025 Meeting
As a provider of high-quality reagents and precision analytical technology, coupled with our extensive expertise in cell and gene therapy, Bio-Techne is primed to partner with you as you develop novel therapies.
Whether you are looking to minimize variability in your process, scale up manufacturing, or transition to GMP-grade raw materials, we can assist you on your journey.
By securing a consistent raw material supply and embracing cutting-edge manufacturing solutions and precision analytics, you can demonstrate robust clinical efficacy and effectively manage cost of goods as you scale toward commercialization.
Featured Sessions at Advanced Therapies Week
Presentation | Closed Systems, Open Possibilities: Considerations for Futureproofing Cell Therapy Manufacturing
Join us for an exploration of closed system manufacturing for cell therapy, covering critical aspects such as upstream processing, cell expansion, and downstream processing. This session will provide you with valuable insights into the essential regulatory, economic, and quality control factors to consider when applying closed system processes to cell therapy production.
Theme/Session: Considering the End Early - What Parts of the Process Can You Get Right From the Start
Presented By: David Hermanson, Ph.D. Principal Scientist, Cell and Gene Therapy Applications, Bio-Techne
Demo | Streamlining Cytokine Delivery for Scalable, Closed System T Cell Manufacturing
Experience a demonstration showing how to achieve optimal dosing of GMP cytokines in a scalable, closed system workflow for T cell culture. Discover how the new ProPak™ GMP Cytokines in weldable bags, streamline and de-risk the cell culture, minimizing risks of error and contamination. See how this approach enhances both scalability and safety in T cell therapy production.
Presented By: David Hermanson, Ph.D. Principal Scientist, Cell and Gene Therapy Applications, Bio-Techne
AT-TV Interview | Closed System CGT Manufacturing: The Future of Scale-up and Commercialization
Join two industry experts from Bio-Techne as they explore the critical challenges and opportunities in closed system manufacturing for cell and gene therapies (CGTs). Our experts examine how innovative manufacturing approaches—particularly closed systems and automation—can help bridge the gap between promising therapies and successful market deployment. The conversation will delve into practical strategies for balancing flexibility and standardization in process development, addressing raw material challenges, and implementing automation effectively.
Featuring Experts:
David Hermanson, Ph.D., Principal Scientist, Cell and Gene Therapy Applications, Bio-Techne
Steven Dublin, Senior Manager, Cell and Gene Therapy - EMEA, Bio-Techne
What's New in Cell & Gene Therapy
Optimize Cytokine Delivery for Scalable T Cell Manufacturing
Optimize Cytokine Delivery for Scalable T Cell Manufacturing
Reduce variability and risk in your T cell therapy with ProPak GMP IL-7 and IL-15 in single-use bags with weldable tubing. ProPak Cytokines are designed for easy integration into closed process workflows with no reconstitution or aliquoting required.
Grow Robust T Cell Cultures for the Clinic
Grow Robust T Cell Cultures for the Clinic
Designed to integrate seamlessly into your pre-clinical or clinical T cell therapy, this GMP T cell media formulation has been adopted by both academic and biopharma clinical programs, mitigating risk associated with IND submissions.
Flex and Fine-Tune T Cell Activation and Expansion
Flex and Fine-Tune T Cell Activation and Expansion
Advance your immune cell therapy program into clinical manufacturing with GMP antibodies for ex vivo use. Our Recombinant Human CD3 GMP Antibody and Human CD28 GMP Antibody are adaptable to your platform and allow you the flexibility to fine-tune your T cell activation and expansion.
Quantify IFN-gamma with Confidence
Quantify IFN-gamma with Confidence
Accelerate QC release with Simple Plex™ immunoassays on the Ella™ automated benchtop ELISA platform. Compliant with 21 CFR Part 11, Ella is the ideal solution for GMP environments. Gain critical insights in just 90 minutes, with pg-level sensitivity and the reproducibility needed to ensure regulatory compliance.
Powerful Analytical Tools for Gene Therapy Development
Powerful Analytical Tools for Gene Therapy Development
As the field of gene therapy continues to grow, comprehensive analytical techniques are essential to ensuring all the critical quality attributes (CQAs) of your vector are met, optimizing your products for maximum therapeutic impact. ProteinSimple suite of scalable and automated analytical solutions can enhance the development of your gene therapy through meticulous, data-driven approaches.
Simplify Your Transition to the Clinic
Simplify Your Transition to the Clinic
Transitioning your cell therapy program from bench to clinic can be a complex and frustrating process. We have vast experience heling customers bring their novel cell therapies to clinical trials. Learn how Bio-Techne makes your transition to GMP as seamless as possible.
Application Notes
- Quantify Secreted T Cell Activation Markers
- Lentiviral Vector Analysis for Cell and Gene Therapy Made Simple
- G-Rex® Fill-and-Forget T Cell Manufacturing Workflow: Touch-free T Cell Expansion
- Analytical Tools to Evaluate CAR-T Cell Signaling & Activation
- Driving CAR-T Therapy to Market in the Fast Lane
- Automation Advancements in Immune Cell Therapy Workflow: IFN-gamma QC Release Testing
- Fast and Reproducible Adeno-Associated Virus Vector Titration with Simple Plex Assays on Ella
Webinars
- Streamlining Immune Cell Therapy Manufacturing Workflows with Process-Sized Cytokine Vials
- Protein Analytics Strategies for Gene Therapy - From Viral Vector Characterization to Clinical Trials
- Automated Immunoassay Platforms for Enhancing AAV Research
Blogs
- Consistency is Critical: Standardization and Quality Control Frameworks for Immune Cell Therapy Development
- GMP Raw Materials: Meeting the Demand for Cell Therapy
- 3 Steps Toward Cell and Gene Therapy Commercialization
- Strengthening Your CAR Toolkit: Analyzing CAR Expression During CAR-T and NK Cell Therapy Development
- Developing Innovative CAR T Cell Therapies to Treat Solid Tumors
| GMP Proteins - Futureproof your cell therapy manufacturing with our GMP cytokines and growth factors. | Request Sample |
| GMP Antibodies - Add flexibility to your immune cell therapy manufacturing workflow with GMP antibodies for T cell activation. | Request Sample |
| ExCellerate™ GMP iPSC Expansion Medium - Achieve robust expansion and extended maintenance of your stem cells. | Request Sample |
| ScaleReady G-Rex® Grant Program - Accelerate you Cell and Gene Therapy with a grant ranging from $5,000 to $300,000. | Learn More and Apply |